Development and Validation of Assay Method for Determination of Quetiapine Fumarate by RP-HPLC from Bulk and Pharmaceutical Dosage Form
Journal: International Journal of Pharmaceutical Sciences and Medicine (IJPSM) (Vol.7, No. 10)Publication Date: 2022-10-30
Authors : Nikita Garhewal; Archana Dubey; P.K Dubey;
Page : 65-96
Keywords : Pharmaceutical Dosage Form; Quetiapine Fumarate;
Abstract
A simple, sensitive, rapid, robust and reproducible method for the determination of Quetiapine fumarate in bulk and pharmaceutical formulation (Tablets) was developed using reverse phase high performance liquid chromatographic method (RP-HPLC). The RP-HPLC analysis was performed The analyte was monitored with UV detector at 290nm. The developed method Quetiapine fumarate elutes at a run time of 10 min. The proposed method is having linearity in the concentration range from 40 to 80 μg/mL of Quetiapine fumarate. The present method was validated with respect to system suitability, linearity, precision, limit of detection (LOD) and limit of quantification (LOQ), accuracy (recovery), ruggedness, and robustness. The proposed method can be readily utilized for bulk drug and pharmaceutical formulation.
Other Latest Articles
- FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF ACECLOFENAC USING NATURAL SUPERDISINTEGRANT
- REVIEW ON OINTMENT
- DISASTERS OF KHATNA OR RELIGIOUS MALE CIRCUMCISION
- SENSITIVITY OF CARBENDAZIM AGAINST ALTERNARIA DAUCI CAUSING LEAF BLIGHT OF CARROT
- AN UNUSUAL CAUSE OF ACUTE ABDOMINAL PAIN IN ONCOLOGY: JEJUNOSTOMY TUBE PLACEMENT COMPLICATION
Last modified: 2022-10-15 23:11:04